CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a novel hydrogel-based therapy for osteoarthritis by encapsulating mesenchymal stromal cells. The injectable hydrogel is designed to enhance cell survival and promote healing in joint tissues, addressing a significant medical challenge.
Osteoarthritis (OA) is an incurable and painful disease.
Over 70 million Europeans are currently affected by OA – a number that is set to increase with aging population and prevalence of obesity.
To date, no clinically-efficient therapy exists to treat this socioeconomically debilitating disease.
In this context, innovative regenerative therapies for joints are a pressing medical challenge.Intraarticular mesenchymal stromal cell (MSC) injections hold the great promise of stopping and reversing a…
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Nantes
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
